Variations and practice in the care of patients with rheumatoid arthritis: Quality and cost of care

Journal of Clinical Rheumatology

Volumn 20, Issue 2, 2014, Pages 79-86

  Demaria, Lisa ^a   Acelajado, Maria Czarina ^b   Luck, Jeff ^c   Ta, Hui ^a   Chernoff, David ^d   Florentino, Jhiedon ^e   Peabody, John W ^f  

^a QURE Healthcare   (United States)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c OREGON STATE UNIVERSITY   (United States)

^d Crescendo Bioscience   (United States)

^e UNIVERSITY OF THE PHILIPPINES   (Philippines)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

health care costs; physician practice patterns; quality of care; rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ADULT; ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMORBIDITY; DISEASE ACTIVITY; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SURVEY; HUMAN; LABORATORY TEST; MALE; MEDICARE; MIDDLE AGED; NORMAL HUMAN; OBSERVATIONAL STUDY; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; VIGNETTE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84896706640     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0000000000000076     Document Type: Article

References (54)

1. Sacks JJ, Luo YH, Helmick CG. Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001-2005. Arthritis Care Res (Hoboken). 2010;62:460-464.
2. Puolakka K, Kautianen H, Möttönen T, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum. 2005;52:36-41.
3. Boers M. Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum. 2003;48:1771-1774.
4. Zatarain E, Strand V. Monitoring disease activity of rheumatoid arthritis in clinical practice: contributions from clinical trials. Nature Clin Prac Rheum. 2006;2:611-618.
5. Harrold LR, Harrington JP, Curtis JR, et al. Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations. Arthritis Rheum. 2012;64:630-638.
6. Beresniak A, Russell AS, Harroui B, et al. Advantages and limitations of utility assessment methods in rheumatoid arthritis. J Rheumatol. 2007;34:2193-2200.
7. Wolfe, F, Rasker JJ, Boers M., et al. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis. Arthritis Rheum. 2007;57:935-942.
8. Pincus T, Yazici Y, Bergman M. A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol. 2007;21:755-787.
9. Pincus T, Strand V, Koch G, et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the ACR 20% response criteria (ACR20) or the Disease Activity Score (DAS) in an RA clinical Trial. Arthritis Rheum. 2003;48:625-630.
10. Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. Baillieres Best Pract Res Clin Reheumatol. 2007;21:663-675.
11. Harrington JT. The uses of disease activity scoring and the physician global assessment of disease activity for managing rheumatoid arthritis in rheumatology practice. J Rheumatol. 2009;36:925-929.
12. Pincus T, Yazici Y, Bergman MJ. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts; similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am. 2009;35:773-778.
13. Jiang Y, Nishikawa RM, Schmidt RA, et al. Potential of computer-aided diagnosis to reduce variability in radiologists' interpretations of mammograms depicting microcalcifications. Radiology. 2001;220: 787-794.
14. Krumholz HM, Normand SL, Spertus JA, et al. Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement. Health Aff (Millwood). 2007;26:75-85.
15. Rat AC, Boissier MC. Rheumatoid arthritis: direct and indirect costs. Joint Bone Spine. 2004;71:518-524.
16. James CD, Peabody JW, Solon O, et al. An unhealthy public-private tension: pharmacy ownership, prescribing, and spending in the Philippines. Health Aff (Millwood). 2009;28:1022-1033.
17. Michaud K, Messer J, Choi HK, et al. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum. 2003;48:2750-2762.
18. Weycker D, Yu EB, Woolley JM, et al. Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged 9=65 year with rheumatoid arthritis. Clin Ther. 2005;27:646-656.
19. Bykerk VP, Schieir O, Akhavan P, et al. Emerging issues in pharmacological management of rheumatoid arthritis: results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations. J Rheumatol. 2012;39:1555-1558.
20. MacLean CH, Louie R, Leake B, et al. Quality of care for patients with rheumatoid arthritis. JAMA. 2000;284:984-992.
21. Cabrero J, Orts MI, López-Coig ML, et al. Variability in the clinical practice of maintaining the patency of peripheral intravenous catheters. Gac Sanit. 2005;19:287-293.
22. Wennberg DE. Variation in the delivery of health care: the stakes are high. Ann Intern Med. 1998;128:866-868.
23. Brook RH, McGlynn EA, Cleary PD. Quality of health care. Part 2: measuring quality of care. N Engl J Med. 1996;335:966-970.
24. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ. 1995;311:793-796.
25. Peabody JW, Luck J, Glassman P, et al. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA. 2000;283: 1715-1722.
26. Peabody JW, Luck J, Glassman P, et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med. 2004;141:771-780.
27. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59:762-784.
28. American College of Rheumatology. 2010 Practice Guidelines. Available at: http://www.rheumatology.org/practice/clinical/guidelines/index.asp. Accessed October 9, 2011.
29. Singh JA, Furst DE, Bharat A, et al. Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 2012;64:625-639.
30. Daihk DI, St Clair W. Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road. Arthritis Care Res. 2012;64:648-651.
31. Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, CA: RAND; 2001.
32. Oehm MJ. Private utilization review. Univ Puget Sound Law Rev. 1991;14:527.
33. Yazday J, Schmajuk G, Robbins M, et al. Choosing wisely: the American College of Rheumatology's top 5 list of things physicians and patients should question. Arthritis Care Res. 2013;65:329-339.
34. Peabody JW, Shimkhada R, Quimbo S, et al. Financial incentives and measurement improved physicians' quality of care in the Philippines. Health Aff (Millwood). 2011;30:773-781.
35. Peabody JW, Florentino J, Shimkhada R, et al. Quality variation and its impact on costs and satisfaction: evidence from the QIDS study. Med Care. 2010;48:25-30.
36. Current Procedural Terminology: CPT 2011 Professional Edition. Chicago, IL: AMA Press; 2010.
37. Physician Fee Schedule. Center of Medicare and Medicaid Services. Available at: https://www.cms.gov/physicianfeesched/downloads/RVU11B-2.zip. Accessed February 20, 2012.
38. Clinical Laboratory Fee Schedule. Center of Medicare and Medicaid Services. Available at: https://www.cms.gov/apps/ama/license.asp?file=/ ClinicalLabFeeSched/downloads/11clab.zip. Accessed February 20, 2012.
39. Buck CJ. HCPCS Level II 2011. St. Louis, MO: Elsevier-Health Science Divisions; 2011.
40. Consumer Report. Treating the Symptoms of Rheumatoid Arthritis: The Biologics. Comparing Effectiveness, Safety, Side Effects and price. Available at: http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/BBD- Rheumatoid-Arthritis-Summary.pdf. Accessed February 24, 2012.
41. Consumer Report. Treating Chronic Pain 2008: The Opioids. Comparing Effectiveness, Safety, and Price. Available at: http://www.consumerreports.org/ health/resources/pdf/best-buy-drugs/Opioids-2pager-FINAL-June2008.pdf. Accessed February 24, 2012.
42. Consumer Report. 2011 Best Buy Drugs: The Non-Steroidal Anti-inflammatory Drugs: Treating Osteoarthritis and Pain Comparing Drug Effectiveness, Safety, and Price. Available at: http://www.consumerreports.org/health/resources/pdf/ best-buy-drugs/Nsaids2.pdf. Accessed February 20, 2012.
43. Consumer Report. 2012 Fish-Oil Pills vs. Claims. Available at: http://www.consumerreports.org/cro/2012/01/fish-oil-pills-vs-claims/index.htm. Accessed February 20, 2012.
44. Consumer Report. 2009 Best Buy Drugs: Evaluating Prescription Drugs Used to Treat Muscle Spasms and Spasticity: The Muscle Relaxants. Comparing Drug Effectiveness, Safety, and Price. Available at: http://www.consumerreports.org/ health/resources/pdf/best-buy-drugs/BBD-Muscle-Relaxants-Report.pdf. Accessed February 20, 2012.
45. Consumer Report. 2011 Best Buy Drugs: Using Antiplatelet Drugs to Treat: Heart Disease, Heart Attacks, and Strokes. Comparing Drug Effectiveness, Safety, and Price. Available at: http://www.consumerreports.org/health/resources/pdf/ best-buy-drugs/Antiplatelets-FINAL.pdf. Accessed February 20, 2012.
46. Consumer Report. 2011 Best Buy Drugs: The Antidepressants: Treating Depression. Comparing Drug Effectiveness, Safety, and Price. Available at: http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/ Antidepressants-update.pdf. Accessed February 20, 2012.
47. Consumer Report. 2011 Best Buy Drugs: Using ACE Inhibitors to Treat High Blood Pressure and Heart Disease Comparing Drug Effectiveness, Safety, and Price. Available at: http://www.consumerreports.org/health/resources/pdf/best- buy-drugs/ACEI-full-report.pdf. Accessed February 20, 2012.
48. Consumer Report. 2011 Drugs to Treat Heartburn and Stomach Acid Reflux: The Proton Pump Inhibitors. Comparing Drug Effectiveness, Safety, and Price. Available at: http://www.consumerreports.org/health/ resources/pdf/best-buy- drugs/ACEI-full-report.pdf. Accessed February 20, 2012.
49. Consumer Report. 2011 Best Buy Drugs: Evaluating the Pegylated Interferon Used to Treat: Hepatitis C. Comparing Effectiveness, Safety, Side Effects, and Price. Available at: http://www.consumerreports.org/health/resources/pdf/best- buy-drugs/BBD-Hepatitis-C-Summary.pdf. Accessed February 20, 2012.
50. Effective Health Care. 2011 Rheumatoid Arthritis Medicines. A Guide for Adults. Available at: http://www.effectivehealthcare.ahrq.gov/ehc/products/14/ 86/RheumArthritisConsumerGuide-Singlepage.pdf. Accessed February 20, 2012.
51. Seo K, Solomon DH. Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatment. Arthritis Res Ther. 2011;13:129.
52. Weeks WB, Gottlieb DJ, Nyweide DE, et al. Higher health care quality and bigger savings found at large multispecialty medical groups. Health Aff. 2010;29:991-997.
53. Korenstein D, Falk R, Howell EA, et al. Overuse of health care services in the United States: an understudied problem. Arch Intern Med. 2012;171-178.
54. Ward MM. Rheumatology visit frequency and changes in functional disability and pain in patients with rheumatoid arthritis. J Rheumatol. 1997;24:35-42.